After the Japanese auto giant’s announcement that it will make 24,000 patents available for licensing royalty-free, we look at its assets reading on vehicle-electrification technologies
In a period of marked change at the board, early numbers suggest the Supreme Court’s landmark decision is leading to greater discretion among petitioners
The Japanese OEM completed a big patent acquisition from Lexmark in 2013 to boost its inkjet business, and a new deal suggests it wants to get more money out of those 1,500 assets
Senior exec at ride-sharing leader reveals how his role has changed, how he has handled the transition from in-house to private practice and back and how he thinks IP strategy is set to evolve.
The high invalidation rate for life science patents in China has created a headache for drug companies and a money-making opportunity for enterprising individuals
No free passes insists Excalibur head as he contemplates future of $250m portfolio after parent company announces dissolution
The Japanese photography and imaging company has focused on developing peripheral technologies to expand into the medical and pharmaceuticals sectors; but while its holdings have increased in quality over the years, it still has a way to go
With so many issues emerging across the entire supply chain, the sector’s IP leaders will be sharing their thoughts and insights at events in Detroit and Munich next month
Number of petitions slumps in the first quarter as petitioners and patent owners come to terms with 12 months of change at the board
How boards of directors can better understand the leading source of a company’s value.
A selection of recently reported facts and figures.
As the fourth industrial revolution gets underway, operating companies need to ensure that their IP strategies are fit for a rapidly changing technological landscape.
"The business places more and more scrutiny on patent spend, and asks the patent team to quantify the value proposition and return on investment,” says David Dutcher
It was a positive fourth quarter of 2018 for US patent sales as an infographic put together based on data supplied by AST shows
As back and forth in landmark patent fight continues USPTO Director Iancu admits clarification needed on controversial 2013 SEP policy statement